Luo J, Avorn J, Kesselheim AS - JAMA Internal Medicine
In this exchange, critics argue that the authors’ analysis of Medicaid insulin reimbursement incorrectly assumed fixed rebate rates, while the authors address the methodological challenge of estimating net prices in a system where actual rebate amounts are confidential.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open